SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. Shanghai Allist Pharmaceuticals Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 748.67 million compared to CNY 300.39 million a year ago. Revenue was CNY 748.67 million compared to CNY 300.39 million a year ago.
Net income was CNY 208.41 million compared to CNY 26.76 million a year ago. Basic earnings per share from continuing operations was CNY 0.46 compared to CNY 0.06 a year ago. Diluted earnings per share from continuing operations was CNY 0.46 compared to CNY 0.06 a year ago.
